Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diarrhea

• Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
• Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
• Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer
• XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
• A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects
• Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
• To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
• Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
• Next Generation ORS: Randomized Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity With Acute Watery Diarrhea in Adults
• Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure)
• Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
• Opium Tincture Against Chronic Diarrhea - Healthy
• Opium Tincture Against Chronic Diarrhea - Patients
• Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
• Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
• A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
• Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
• Examining the Effect of Ondansetron on Bowel Prep Success
• Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
• Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome
• Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
• Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
• Microbiotic Product (NBT-NM108) to Reduce Chemotherapy-Induced Diarrhea
• S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
• Trial to Evaluate Diarrhoea Discontinuations at 3 Cycles in Patients With Early-stage HER2+, HR+ Breast Cancer Treated With Neratinib Plus Loperamide Versus Neratinib Dose Escalation Plus Loperamide Administered as Needed Versus Neratinib Plus Loper
• Anti-Secretory Drug in Treatment of Acute Watery Diarrhea
• Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
• The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure
• A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
• Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years
• Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine
• XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
• Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in Children
• A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• GI Permeability Change in Response to Aquamin®
• Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)
• EFFECTIVENESS OF FOLIC ACID IN ACUTE WATERY DIARRHEA AMONG CHILDREN
• Management of Shock in Children With SAM and Diarrhea
• Prevention and Treatment of Pyrrolitinib-associated Diarrhea
• Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl
• Efficacy and Safety of Rifaximin With NAC in IBS-D
• Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• Crofelemer for Functional Diarrhea
• Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy
• Mechanisms of Probiotics and Antibiotic-Associated Diarrhea
• Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.
• Investigation of Eluxadoline for Diabetic Diarrhea
• Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome
• Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
• Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients
• Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
• Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea
• Antibiotic-Associated Diarrhea and the Role of Microorganisms in the Gut
• Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
• A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
• Zinc Sulfate Acceptability
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
• Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
• Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
• Efficacy and Safety of Teicoplanin in CDAD
• The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
• Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)
• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
• Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients
• Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea
• Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery
• Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
• Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
• Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
• A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea
• A Study of Colesevelam for Lenalidomide-Associated Diarrhea
• Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
• Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
• Non-specific Effects of Rabies Vaccine
• Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form in Patients With Acute Diarrhea
• The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
• Oral Administration of Tannins and Flavonoids vs Sacchaomyces Boulardii in Pediatric Acute Diarrhea
• Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
• TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
• Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
• Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence
• A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated Diarrhea
• Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea
• Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea
• Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
• Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
• Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
• Eluxadoline Bile Acid Malabsorption (BAM) Study
• TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment
• Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease
• Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea
• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
• Antibiotics for Children With Severe Diarrhoea
• Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
• Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
• Incidence and Severity of Diarrhea in Patients With Stage II-IIIC HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
• Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
• Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
• Bacillus Particles Prevent Children Antibiotics Associated Diarrhea
• Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients
• Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
• ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects
• Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
• A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
• Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
• Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial
• Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile
• A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)
• A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)
• Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
• Prevention of Irinotecan Induced Diarrhea by Probiotics
• Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
• A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency
• Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
• An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• C. Difficile and Ursodiol
• Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea
• Study of the Efficacy and Tolerance of Oral Treatment With a Total Freeze-dried Culture of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2
• To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.
• Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir
• Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
• Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
• Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea
• Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
• Special Drug Use Surveillance of Irribow in Female Patients
• Heweizhixie capsuleTherapy on Patients With Diarrhea
• The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children
• Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome
• Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
• Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
• Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
• Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)
• Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and Flatulence
• Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
• Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
• A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
• Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
• Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
• A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
• Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
• Efficacy of iOWH032 in Dehydrating Cholera
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
• Impact of Oral Antibiotic Treatment on C. Difficile
• Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan
• CASAD for Severe Diarrhea in the Emergency Department
• Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea
• Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea
• A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
• Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan
• Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan
• Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase
• Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)
• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation
• PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera
• Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®
• ADAM-Afatinib Diarrhea Assessment and Management
• Lactobacillus Preparation on the Incidence of Diarrhea
• Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
• The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
• A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
• Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)
• Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea
• The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome
• Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
• A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)
• Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)
• Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
• Obeticholic Acid in Bile Acid Diarrhoea
• Efficacy of Racecadotril in Acute Watery Diarrhea in Children
• Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants
• Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection
• Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children
• A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis
• The Effect of Neu-P11 on Symptoms in Patients With D-IBS
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
• Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea
• Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
• A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
• The Treatment Effect of Bio-Three on Children With Enteritis
• Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products
• Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
• Prophylaxis of Gastrointestinal Infections With EcN
• Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome
• Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
• Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
• Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
• Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults
• Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
• Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
• Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial
• Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
• Nitazoxanide for the Treatment of Prolonged Diarrhea in Children
• Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
• Zinc Supplementation and Severe and Recurrent Diarrhea
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)
• The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis
• Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy
• A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
• Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital
• Llama Antibody, Rotavirus Diarrhoea, Children
• A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
• Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)
• Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
• Oral Zinc for the Treatment of Acute Diarrhea in US Children
• Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
• Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
• Safety, Efficacy and Cost-effectiveness of Racecadotril in Children With Acute Diarrhea in Mexico
• Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea
• Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
• Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
• Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
• Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
• Study of CB-183,315 in Participants With Clostridium Difficile Infection
• A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
• Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea
• A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
• Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children
• Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
• Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea
• Trial of Mesalamine for the Treatment of Active Microscopic Colitis
• A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?
• Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea
• Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
• A Comparison of Three Medications to Treat Diarrhea in Adults.
• Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
• Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies
• Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)
• Rifaximin for Prevention of Travellers' Diarrhea
• Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea
• Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus
• Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea
• A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea
• Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy
• Saccharomyces Boulardii in Irritable Bowel Syndrome
• Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea
• Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
• Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome
• The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
• Impact of Home Zinc Treatment for Acute Diarrhea in Children
• Probiotics: is it Really That Good? Cost-Effectiveness of Treating the in-Patient
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
• New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management- Surveillance Study for Adverse Effects
• PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
• A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea
• Effect of Probiotics (Bio-Three) in Children's Enterocolitis
• Diarrhea Predominant Irritable Bowel Syndrome in Females
• ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children
• Preventing Antibiotic-Associated DiarRhea Using Erceflora
• Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -
• Immunological and Clinical Responses to Zinc in Children With Diarrhoea
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM
• A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
• A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial
• Zinc-ORS in Severe and Complicated Acute Diarrhea
• Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation
• Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea
• Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children
• Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children
• Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition
• SAFEstart Feeding Intolerance Study Phase II
• Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.
• Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children
• Oral Rehydration SolutionContaining Amylase Resistant Starch in Severely Malnourished Children.
• Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)
• Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
• Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
• Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
• Effectiveness of Adding Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
• Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
• Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled Trial
• Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children
• Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
• A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
• TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children
• Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
• Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk
• Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
• Introduction of Hypo-osmolar ORS for Routine Use
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
• Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study
• Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
• A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
• A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
• Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment
• Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
• IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
• Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea
• Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
• Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS
• Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance
• HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition
• Long-term Impact and Intervention for Diarrhea in Brazil
• Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
• Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants
• A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
• Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
• OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
• N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
• A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
• For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
• Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
• A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
• A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
• A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Co
• A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
• Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea
• Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial
• Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
• A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
• A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea